APD

Air Products and Chemicals – A Fast Overview

Shares of Industrials sector company Air Products and Chemicals moved 3.8% today, and are now trading at a price of $279.98. The Large-Cap stock's daily volume was 1,417,922 compared to its average volume of 1,516,122. The S&P 500 index returned a -0.0% performance.

Air Products and Chemicals, Inc. provides atmospheric gases, process and specialty gases, equipment, and related services in the Americas, Asia, Europe, the Middle East, India, and internationally. The company is based in Allentown and has 23,000 full time employees. Its market capitalization is $62,241,234,944. Air Products and Chemicals currently offers its equity investors a dividend that yields 2.6% per year.

21 analysts are following Air Products and Chemicals and have set target prices ranging from $210.0 to $355.0 per share. On average, they have given the company a rating of buy. At today's prices, APD is trading 3.55% away from its average analyst target price of $270.37 per share.

Over the last year, APD shares have gone down by -3.2%, which represents a difference of -27.7% when compared to the S&P 500. The stock's 52 week high is $307.71 per share and its 52 week low is $212.24. Air Products and Chemicals has averaged free cash flows of $-721033333.3 over the last 5 years, with a mean growth rate of -18.0%. It is likely that the stock will keep following its current negative performance trend while the underlying business is experiencing such poor cash flows.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2023 3,205,700 4,626,400 -1,420,700 27.85
2022 957,400 2,926,500 -1,969,100 -20.22
2021 826,300 2,464,200 -1,637,900 -30.25
2020 1,251,500 2,509,000 -1,257,500 -228.29
2019 2,969,900 1,989,700 980,200 0.14
2018 2,547,200 1,568,400 978,800
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS